Indaptus Therapeutics is trading at $2.56, up 7.29% in pre-market; available evidence does not establish a specific cause.
- The previous session closed at $2.39.
- No new company announcement dated October 14 was found. The private-placement deadline extension was reported September 30 and is not a confirmed overnight catalyst.
- Broad indices were lower, which does not explain the move.